Michael Yehuda Mashaal

Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston.

HealthCor Partners Fund LP invests in companies located in the US. The fund targets the companies operating in the fields of healthcare and life sciences. The fund provides financing in the form of equity and debt for restructurings, recapitalizations, later stage requirements, buyouts , acquisitions and other special situations with an investment size ranges between $5 million to $25 million in each portfolio company . The fund makes minority and/or control investments. The fund also invests in public companies.

ReShape Medical, Inc. develops non-surgical medical devices for the treatment of obesity. The company is headquartered in San Mateo, CA.

HealthCor Group LLC provides investment advisory services to private investment funds. The company is headquartered in New York, NY.

Your Internet Defender, Inc. operates as a holding company with interests in vascular robotic assisted systems. The company through its subsidiary designs, manufactures and sell CorPath precision vascular robotic-assisted systems for use in interventional vascular procedures. Its flagship product, the CorPath Vascular Robotics System, brings the vascular robotic system to facilitate stent placement for percutaneous coronary intervention procedures performed in an interventional cath lab in which the physician uses a control panel console located within an interventional cockpit to measure, manipulate, and advance devices with robotic precision. The company was founded on May 4, 2011 and is headquartered in Waltham, MA.

HealthCor Partners Fund II LP invests primarily in later-stage developmental and growing (private or publicly traded) mid-sized companies across all sectors of the healthcare and life sciences industry. The fund makes minority and controlling investments. It backs experienced management teams in leveraged buyouts and in creating growing companies through a series of acquisitions. It also selectively invests in restructurings, recapitalizations and other special situations involving more established healthcare companies. It makes equity and equity related investments between USD 5 - 25 million in each portfolio company.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.